Treatment News : Body Satisfaction Increased With Fat Gains in Prezista Study

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » June 2011

Most Popular Links
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

15 Years Ago In POZ


More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailprint

June 17, 2011

Body Satisfaction Increased With Fat Gains in Prezista Study

Although treatment experienced HIV-positive men and women had slightly greater gains in trunk fat after switching to a new regimen containing Prezista (darunavir), they also reported increased satisfaction with their bodies. These data were published in the July issue of AIDS Patient Care and STDs.

Of all of the side effects to HIV medication, body shape changes—both the loss of body fat in the face and limbs and gains of body fat in the trunk and other areas—are among the most distressing to people living with HIV. In fact, body shape changes have been identified as an independent cause of adherence problems in people taking antiretroviral (ARV) therapy.

Though body shape changes are less of a risk with the drugs that are more commonly used today, they do still occur in some people. This is particularly true in people who are heavily treatment experienced, who must sometimes combine the newer ARV drugs with older medication.

To determine the impact of Prezista on body shape changes and people’s perception of their bodies, Judith Currier, MD, from the University of California in Los Angeles, and her colleagues examined data from a large study of Norvir (ritonavir)–boosted Prezista in a diverse group of treatment-experienced people. The study, called GRACE, was the first that was specifically designed to compare the safety and effectiveness of an ARV medication between men and women and between white and black study participants.

In this particular analysis, Currier and her colleagues measured changes in trunk over time and also surveyed the GRACE study participants about their perceptions of their bodies and their satisfaction with their appearance. In all, 287 HIV-positive women and 142 HIV-positive men were examined for this analysis, all of whom received at least one dose of Prezista. In general, women in the study had less severe HIV disease progression at the study’s start.

Currier’s team found that although the participants gained weight and their waist size increased during the course of the study—by 2.5 centimeters (cm) in women and 1.3 cm in men—the participants nevertheless reported greater body satisfaction by the end of the study. In women, those who reported being either “satisfied” or “very satisfied” with their body appearance increased from 42 percent to 58 percent over the course of the study. In men, those “satisfied” or “very satisfied” increased from 56 percent to 63 percent.

Given the discrepancy between people’s actual body shape changes and their reported satisfaction with their bodies, the authors are calling for further study. First, the authors suggest that additional exploration is needed to better understand the reasons behind the body shape changes. Second, they urge that we need a better and more thorough understanding about how people perceive their bodies and how this may affect adherence.

Search: GRACE study, Prezista, darunavir, Norvir, ritonavir, fat, trunk fat, waist, body satisfaction


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Hide comments

Previous Comments:


  comments 1 - 1 (of 1 total)    

poz83diag92alive2011, , 2011-06-20 05:43:25
What a waste of resources IMHO. I mean nobody is happier being made fat by meds but given the fact they feel better obviously their sense of well being promotes better feeling of being normal...to say I like being fatter after 18 years of chemotoxic crud therapy is a joke. I have to exercise a full hour a day just to keep diabetes at bay with Metformin-meds so riddled with side effects - time for gene therapy nrrf to end the profiting on sick people-the hep c "cure" is now 100k-gouging the weak.

comments 1 - 1 (of 1 total)    


[Go to top]


Join POZ Facebook Twitter Google+ MySpace YouTube Tumblr Flickr
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar


    dambitious
    Gone
    New York


    usuallyhappy
    Palm Springs
    California


    TaintedloveDC
    Washington
    DC


    robert12
    Queens
    New York
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Do you work with your doc to design your own treatment regimen?
Yes
No

Survey
PrEP Course

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.